These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 29459033)

  • 1. Defining Pharmacological Targets by Analysis of Virus-Host Protein Interactions.
    Llano M; Peña-Hernandez MA
    Adv Protein Chem Struct Biol; 2018; 111():223-242. PubMed ID: 29459033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A broad-spectrum antiviral molecule, QL47, selectively inhibits eukaryotic translation.
    de Wispelaere M; Carocci M; Burri DJ; Neidermyer WJ; Olson CM; Roggenbach I; Liang Y; Wang J; Whelan SPJ; Gray NS; Yang PL
    J Biol Chem; 2020 Feb; 295(6):1694-1703. PubMed ID: 31914414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein-protein interactions as targets for antiviral chemotherapy.
    Loregian A; Marsden HS; Palù G
    Rev Med Virol; 2002; 12(4):239-62. PubMed ID: 12125015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Agonist of the TRIF Pathway Induces a Cellular State Refractory to Replication of Zika, Chikungunya, and Dengue Viruses.
    Pryke KM; Abraham J; Sali TM; Gall BJ; Archer I; Liu A; Bambina S; Baird J; Gough M; Chakhtoura M; Haddad EK; Kirby IT; Nilsen A; Streblow DN; Hirsch AJ; Smith JL; DeFilippis VR
    mBio; 2017 May; 8(3):. PubMed ID: 28465426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Respiratory syncytial virus entry and how to block it.
    Battles MB; McLellan JS
    Nat Rev Microbiol; 2019 Apr; 17(4):233-245. PubMed ID: 30723301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New World alphavirus protein interactomes from a therapeutic perspective.
    Carey BD; Bakovic A; Callahan V; Narayanan A; Kehn-Hall K
    Antiviral Res; 2019 Mar; 163():125-139. PubMed ID: 30695702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of herpesvirus and influenza virus replication by blocking polymerase subunit interactions.
    Palù G; Loregian A
    Antiviral Res; 2013 Sep; 99(3):318-27. PubMed ID: 23748148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sirtuin Inhibitors Are Broadly Antiviral against Arboviruses.
    Hackett BA; Dittmar M; Segrist E; Pittenger N; To J; Griesman T; Gordesky-Gold B; Schultz DC; Cherry S
    mBio; 2019 Jul; 10(4):. PubMed ID: 31289184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent and selective inhibition of pathogenic viruses by engineered ubiquitin variants.
    Zhang W; Bailey-Elkin BA; Knaap RCM; Khare B; Dalebout TJ; Johnson GG; van Kasteren PB; McLeish NJ; Gu J; He W; Kikkert M; Mark BL; Sidhu SS
    PLoS Pathog; 2017 May; 13(5):e1006372. PubMed ID: 28542609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of Protein-Protein Interaction Inhibitors for the Treatment of Infectious Diseases.
    Voter AF; Keck JL
    Adv Protein Chem Struct Biol; 2018; 111():197-222. PubMed ID: 29459032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virus-host interactomes--antiviral drug discovery.
    Ma-Lauer Y; Lei J; Hilgenfeld R; von Brunn A
    Curr Opin Virol; 2012 Oct; 2(5):614-21. PubMed ID: 23057872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small molecules targeting viral RNA.
    Hermann T
    Wiley Interdiscip Rev RNA; 2016 Nov; 7(6):726-743. PubMed ID: 27307213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The domain landscape of virus-host interactomes.
    Zheng LL; Li C; Ping J; Zhou Y; Li Y; Hao P
    Biomed Res Int; 2014; 2014():867235. PubMed ID: 24991570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza virus-host interactomes as a basis for antiviral drug development.
    Watanabe T; Kawaoka Y
    Curr Opin Virol; 2015 Oct; 14():71-8. PubMed ID: 26364134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. All-Atom Molecular Dynamics of Virus Capsids as Drug Targets.
    Perilla JR; Hadden JA; Goh BC; Mayne CG; Schulten K
    J Phys Chem Lett; 2016 May; 7(10):1836-44. PubMed ID: 27128262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond Channel Activity: Protein-Protein Interactions Involving Viroporins.
    To J; Torres J
    Subcell Biochem; 2018; 88():329-377. PubMed ID: 29900504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase Transitions Drive the Formation of Vesicular Stomatitis Virus Replication Compartments.
    Heinrich BS; Maliga Z; Stein DA; Hyman AA; Whelan SPJ
    mBio; 2018 Sep; 9(5):. PubMed ID: 30181255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virus-Host Interactions: New Insights and Advances in Drug Development Against Viral Pathogens.
    Prasad M; Ranjan K; Brar B; Shah I; Lalmbe U; Manimegalai J; Vashisht B; Gaury M; Kumar P; Khurana SK; Prasad G; Rawat J; Yadav V; Kumar S; Rao R
    Curr Drug Metab; 2017; 18(10):942-970. PubMed ID: 28952435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies of development of antiviral agents directed against influenza virus replication.
    Hsieh HP; Hsu JT
    Curr Pharm Des; 2007; 13(34):3531-42. PubMed ID: 18220789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein Phosphatase-1 regulates Rift Valley fever virus replication.
    Baer A; Shafagati N; Benedict A; Ammosova T; Ivanov A; Hakami RM; Terasaki K; Makino S; Nekhai S; Kehn-Hall K
    Antiviral Res; 2016 Mar; 127():79-89. PubMed ID: 26801627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.